Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Hu

Showing results (251-260 of 3,392) with videos related to

Pageof 340
Sort By:
The American Journal of Pathology|January 21, 2023
YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA StabilityXin Li, KeJing Zhang, Yu Hu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 14, 2013
[A case report of portopulmonary hypertension]Pei Wang, Yu-hu Song, Ke-shu Xu
Leukemia & Lymphoma|August 3, 2013
Association between MTR A2756G polymorphism and childhood acute lymphoblastic leukemia: a meta-analysisJia Xia, Yadan Wang, Hang Zhang, et al.
Zhongguo Yi Miao He Mian Yi|January 19, 2010
[Isolation identification and serological analysis on varicella-zoster virus from an outbreak in Shanghai in 2007]Jing Lu, Chong-Shan Li, Jia-Yu Hu
Huan Jing Ke Xue= Huanjing Kexue|July 3, 2018
[Characteristics of Industrial VOCs Emission Sources and Control Technology Application in a Prefecture-level City Region-Based on Qinhuangdao City]Xu-Rui Hu, Xiao-Yu Hu, Can Wang
Journal of Cancer Research and Therapeutics|December 13, 2018
Symptomatic treatment of brain metastases in renal cell carcinoma with sorafenibDongyan Hu, Yu Hu, Jisheng Li, et al.
Frontiers in Immunology|November 16, 2020
Cord-Blood Natural Killer Cell-Based Immunotherapy for CancerXiaoyan Zhao, Li Cai, Yu Hu, et al.
The American Journal of the Medical Sciences|March 24, 2015
A Patient With BCR-ABL and JAK2 V617F Double-Positive Myeloproliferative Neoplasm With Overlapping Clinical PhenotypesYadan Wang, Jia Xia, Xiaofei Wu, et al.
Bioscience Reports|January 3, 2020
ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaptionXin Li, Kejing Zhang, Yu Hu, et al.
Lancet (London, England)|January 20, 2024
Concerns about the ALIFE2 trialLiang V Tang, Zhi-Peng Cheng, Yu Hu
Pageof 340

Showing results (251-260 of 3,392) with videos related to

Sort By:
Pageof 340
The American Journal of Pathology|January 21, 2023
YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA StabilityXin Li, KeJing Zhang, Yu Hu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 14, 2013
[A case report of portopulmonary hypertension]Pei Wang, Yu-hu Song, Ke-shu Xu
Leukemia & Lymphoma|August 3, 2013
Association between MTR A2756G polymorphism and childhood acute lymphoblastic leukemia: a meta-analysisJia Xia, Yadan Wang, Hang Zhang, et al.
Zhongguo Yi Miao He Mian Yi|January 19, 2010
[Isolation identification and serological analysis on varicella-zoster virus from an outbreak in Shanghai in 2007]Jing Lu, Chong-Shan Li, Jia-Yu Hu
Huan Jing Ke Xue= Huanjing Kexue|July 3, 2018
[Characteristics of Industrial VOCs Emission Sources and Control Technology Application in a Prefecture-level City Region-Based on Qinhuangdao City]Xu-Rui Hu, Xiao-Yu Hu, Can Wang
Journal of Cancer Research and Therapeutics|December 13, 2018
Symptomatic treatment of brain metastases in renal cell carcinoma with sorafenibDongyan Hu, Yu Hu, Jisheng Li, et al.
Frontiers in Immunology|November 16, 2020
Cord-Blood Natural Killer Cell-Based Immunotherapy for CancerXiaoyan Zhao, Li Cai, Yu Hu, et al.
The American Journal of the Medical Sciences|March 24, 2015
A Patient With BCR-ABL and JAK2 V617F Double-Positive Myeloproliferative Neoplasm With Overlapping Clinical PhenotypesYadan Wang, Jia Xia, Xiaofei Wu, et al.
Bioscience Reports|January 3, 2020
ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaptionXin Li, Kejing Zhang, Yu Hu, et al.
Lancet (London, England)|January 20, 2024
Concerns about the ALIFE2 trialLiang V Tang, Zhi-Peng Cheng, Yu Hu
Pageof 340